In the News | Friends of Cancer Research

You are here

In the News

September 21, 2010
Dr. Ellen Sigal named to Patient Centered Outcomes Research Institute Board of Governors Chair of Friends of Cancer Research Appointed as One of 19 Member Board for Comparative Effectiveness Research... Read more
September 19, 2010
By AMY HARMON, Growing up in California’s rural Central Valley, the two cousins spent summers racing dirt bikes and C hristmases at their grandmother’s on the coast. Endowed with a similar brash... Read more
September 16, 2010
Editorial, The Congressional Budget Office estimates that an astonishing half or more of the increased spending for health care  in recent decades is due to technological, surgical and clinical... Read more
September 9, 2010
By PETE YOST, WASHINGTON — A federal appeals court on Thursday permitted federal funding of stem cell research to proceed for now , while it considers a judge's ruling that had temporarily shut off... Read more
September 1, 2010
By Jeremy Pelofsky WASHINGTON (Reuters) - The Obama administration asked a federal judge on Tuesday to lift an injunction halting human  embryonic stem cell research, saying it would irreparably... Read more
August 25, 2010
By Rob Stein,   The National Institutes of Health announced Tuesday that it has suspended funding  new human embryonic stem cell research and that all federally funded experiments already underway... Read more
August 23, 2010
Ruling could stop NIH stem cell funding (cancer research), Judge says even paying for research harms embryos By Jeremy Pelofsky and Maggie FoxWASHINGTON, Aug 23 (Reuters) - A U.S. district court... Read more
August 17, 2010
By Henry I. Miller and Jeff Stier,The recent high-profile case involving Avastin shouldn't be a black mark against the entire system. An important but obscure aspect of the Food and Drug... Read more
August 16, 2010
By Rob Stein Federal regulators are considering taking the highly unusual step of rescinding approval of a drug that patients with advanced breast cancer turn to as a last-ditch hope.   The debate... Read more